“…A novel cationic iodinated contrast agent, CA4+, was specifically designed to electrostatically interact with glycosaminoglycans (GAGs) bound in proteoglycans [ 16 ]. In particular, the Coulomb attraction between negative fixed charges of GAGs and positively-charged CA4+ molecules showed superior contrast enhancement compared to commercially available contrast agents, (even at lower concentrations [ 17 , 18 , 19 ]), in animal [ 20 , 21 , 22 , 23 ] and human [ 24 , 25 , 26 , 27 , 28 , 29 ] samples, on several types of tissue containing GAGs [ 13 , 30 , 31 ] and cartilage tissue-engineered constructs [ 32 ]. The use of CA4+ was investigated in combination with synchrotron radiation as well, exploiting the high brilliance and monochromaticity of X-ray beam [ 33 , 34 , 35 , 36 ].…”